Tuesday, August 19, 2014 5:05:47 PM
Craig seems to be less confidence about long runway as the sole generic as FDA has dragged far too long and thus ppl might have caught up and fda might give out info to them like in mC
Still hoping for near term approval.
As risk liability will not be on mnta, but mnta is willing to give up its revenue if things happen.
A few comments on mc patents, to me, it indicates they will launch if it is up to them.
Pipeline talk, some interesting stuffs there. 402 is rather interesting and will have some more on it soon.
All in all, lots of news coming up.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM